Scientific Sessions 2025  /  New Onset HFpEF and “LVH”—Don't Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025  /  I’m am Worried My Patient May have Cardiac Amyloidosis. A Practical Algorithm to Make the Diagnosis.
Logo

American Heart Association

  40
  0

Final ID:

I’m am Worried My Patient May have Cardiac Amyloidosis. A Practical Algorithm to Make the Diagnosis.

  • Hanna, Mazen  ( CLEVELAND CLINIC , Cleveland , Ohio , United States )
  • Sailer, Christine  ( University of Colorado , Aurora , Colorado , United States )
  • Kittleson, Michelle  ( Cedars Sinai , Beverly Hills , California , United States )
    • Author Disclosures:
    Mazen Hanna: DO have relevant financial relationships ; Advisor:Pfizer:Active (exists now) ; Advisor:Alnylam:Active (exists now) ; Advisor:ATTRALUS:Active (exists now) ; Advisor:Alexion:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Bridge Bio:Active (exists now) | Christine Sailer: DO NOT have relevant financial relationships | Michelle Kittleson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

New Onset HFpEF and “LVH”—Don't Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Solid Organ Transplant for Cardiac Amyloidosis: Historical Relic or Modern Necessity?

Ambardekar Amrut, Panjrath Gurusher

Do Emerging HFpEF Treatments Work? The Role of Non-disease Modifying Treatments including SGLT2i, MRAs, GLP1s, and implantable hemodynamic monitors in Cardiac Amyloidosis.

Cuddy Sarah, Griffin Jan

More abstracts from these authors:
Genetic Dilated Cardiomyopathies: Can Preventive GDMT Help?

Tang Wai Hong, Khazanie Prateeti, Sailer Christine

Navigating Clinical Challenges: Situation Room Discussion on ATTR Cardiac Amyloidosis

Hanna Mazen

You have to be authorized to contact abstract author. Please, Login
Not Available